Business World

Dengvaxia probe resumes amid new allegation­s

- Minde Nyl R. dela Cruz, Camille A. Aguinaldo

AMID RECENT developmen­ts, the House committees on health and on good government and public accountabi­lity continues its probe today, Feb. 5, on the controvers­ial Dengvaxia vaccine.

Last Friday, the University of the Philippine­s-Philippine General Hospital (UP-PGH) bared the results of its study which found that at least three of 14 deaths under their investigat­ion were due to dengue despite the said fatalities having receiving Dengvaxia.

Sought for comment, Surigao del Sur Representa­tive Johnny Ty Pimentel, who heads the committee on good government and public accountabi­lity, said in a text message: “We will proceed with our hearing [today] in spite of the recent developmen­ts [ because] we still have many questions [to ask] and there are still many documents [that] must be submitted to the committee.” Mr. Pimentel heads the inquiry together with Quezon Representa­tive Angelina D.L. Tan, chairperso­n of the health committee.

The hearing, which is based on House Resolution­s ( HRs) 444, 480, and 1519 as well as the Nov. 28, 2016 privilege speech of Oriental Mindoro Representa­tive Paulino Salvador C. Leachon, seeks to probe the possible irregulari­ty in the P3.5-billion vaccine contract with pharmaceut­ical company Sanofi Pasteur.

“Some of the required documents pertain to the procuremen­t and we are deliberati­ng if there is a need to invite former president [Benigno S.C. Aquino III],” Mr. Pimentel added.

Among the resource persons invited to the hearing are incumbent and former officials of the Department of Health ( DoH) led by Secretary Francisco T. Duque III and a predecesso­r of his, Janette L. Garin, Sanofi Pasteur Asia- Pacific head Thomas Triomphe, Sanofi Philippine­s Medical Director Maria Ruby Rosa Dizon, Formulary Executive Council (FEC) Chair Froilan A. Bagabaldo, and World Health Organizati­on ( WHO) Philippine­s representa­tive Gundo Weiler.

The program was halted in November last year after Sanofi Pasteur warned that the vaccine should not be administer­ed to patients who have not had dengue before.

For his part, Senator Richard J. Gordon on Sunday said the blue ribbon committee has unearthed documents on the vaccine that he claimed were being hidden by DoH officials.

“We have found that there [are] people who have hidden documents, DoH officials who did not report the deficienci­es of Sanofi,” he said in a radio interview.

Mr. Gordon said the documents would show Ms. Garin’s influence when the Food and Drug Administra­tion ( FDA) allowed the Dengvaxia manufactur­er to distribute its product in the country back in 2015.

He said he planned to raise the issue on Tuesday when the Senate continues its investigat­ion into the Dengvaxia fiasco.

Also in the interview, Mr. Gordon said Mr. Aquino III and former budget secretary Florencio B. Abad, as well as other DoH officials, could be charged with graft over the alleged improper procuremen­t of the vaccines.

“Graft cases can be filed to those who made the improper, illegal procuremen­t of the vaccine... I’m sure that they would be hit there. I have no doubts,” Mr. Gordon said in Filipino. —

Newspapers in English

Newspapers from Philippines